Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates-Reference-Cited by-同舟云学术

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

Published:2012-01-22 Issue:2 Volume:30 Page:184-189
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Shen Ben-Quan,Xu Keyang,Liu Luna,Raab Helga,Bhakta Sunil,Kenrick Margaret,Parsons-Reponte Kathryn L,Tien Janet,Yu Shang-Fan,Mai Elaine,Li Dongwei,Tibbitts Jay,Baudys Jakub,Saad Ola M,Scales Suzie J,McDonald Paul J,Hass Philip E,Eigenbrot Charles,Nguyen Trung,Solis Willy A,Fuji Reina N,Flagella Kelly M,Patel Darshana,Spencer Susan D,Khawli Leslie A,Ebens Allen,Wong Wai Lee,Vandlen Richard,Kaur Surinder,Sliwkowski Mark X,Scheller Richard H,Polakis Paul,Junutula Jagath R

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt.2108.pdf

Reference24 articles.

1. Carter, P.J. & Senter, P.D. Antibody-drug conjugates for cancer therapy. Cancer J. 14, 154–169 (2008).

2. Polakis, P. Arming antibodies for cancer therapy. Curr. Opin. Pharmacol. 5, 382–387 (2005).

3. Kreitman, R.J. & Pastan, I. Immunotoxins for targeted cancer therapy. Adv. Drug Deliv. Rev. 31, 53–88 (1998).

4. Marik, J. & Junutula, J.R. Emerging role of immunoPET in receptor targeted cancer therapy. Curr. Drug Deliv. 8, 70–78 (2011).

5. Ryan, S.M., Mantovani, G., Wang, X., Haddleton, D.M. & Brayden, D.J. Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin. Drug Deliv. 5, 371–383 (2008).

Cited by 853 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development;Journal of Medicinal Chemistry;2024-08-28

2. Peptide and Protein Cysteine Modification Enabled by Hydrosulfuration of Ynamide;ACS Central Science;2024-08-21

3. Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy;Journal of Ovarian Research;2024-08-08

4. Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs;World Journal of Oncology;2024-08

5. Understanding the Effects of Site-Specific Light Chain Conjugation on Antibody Structure Using Hydrogen Exchange-Mass Spectrometry (HX-MS);Journal of Pharmaceutical Sciences;2024-08